Sensitive assay for plasminogen activator of transformed cells. 1980

H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel

A sensitive in situ assay for the plasminogen activator of transformed cells is described; it uses the fluorogenic molecule 3',6'-bis(4-guanidinobenzoyloxy)-5-(N'-4-carboxylphenyl)thioureidospiro[isobenz ofuran-1(3H),9'-[9H]xanthen]-3-one. This fluorescein derivative is an excellent active-site titrant of the esterase activity of plasmin. When transformed cells are incubated with purified plasminogen and the resulting plasmin is titrated with the fluorogenic substrate, the amount of plasmin formed is linearly proportional to time and cell number. The assay is sensitive enough to detect quantitatively the plasminogen activator activity of as few as 250 transformed cells. This substrate should be useful in studying quantitatively the correlation between increased levels of plasminogen activator activity and cellular transformation and as a general active site titrant of serine proteases.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
September 1982, Thrombosis research,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
January 1980, Progress in clinical and biological research,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
June 1974, Cell,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
April 1978, Cancer research,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
October 1981, American journal of clinical pathology,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
September 1980, The Journal of general virology,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
January 1979, Biochimie,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
May 1981, Molecular and cellular biology,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
January 1981, Annals of the New York Academy of Sciences,
H Y Liu, and G A Peltz, and S P Leytus, and C Livingston, and J Brocklehurst, and W F Mangel
September 1980, Analytical biochemistry,
Copied contents to your clipboard!